ARCHIVES

Caution Advised for Hormone Replacement Therapy

This article is from The Cancer Letter archive.

Vol. 12 No. 12 | March 21, 1986

Download PDF Visit The Full Archive

Related Articles

NCI’s Share Of Gramm-Rudman Cuts For FY 1986 Is $54 Million; Staff Ponders How To Absorb It

January 24, 1986

Questions Still Surround 88 BCDDP Patients Found With Minimal Cancer; DCCR Asks for Another Review

October 28, 1977

Perifosine Fails Primary Endpoint, Zentaris CEO Explores Options

April 27, 2012

NCI Advisory Group, Other Cancer Meetings

July 29, 1983

In Brief: Donald Metcalf Wins Bristol-Myers Award; NCI Starts Search for Biological Carcinogenesis AD

May 1, 1987

Includes 8-page April 2002 Business & Regulatory Report.

May 3, 2002